Report Code : A01718
The rise in technological advancements, especially nanopore sequencing in NGS and rise in the need to improve diagnostic procedures and ensure quality treatment is propelling the development is propelling the development of next generation sequencing market.
Onkar Sumant
Manager, Healthcare at Allied Market Research
According to a new report published by Allied Market Research, titled, “Next Generation Sequencing Market by Product Type, Application, Technology, End user, and: Opportunity Analysis and Industry Forecast, 2020-2030,” The global next generation sequencing market size was valued at $6,598.62 million in 2020, and is projected to reach $35,503.66 million by 2030, registering a CAGR of 18.2% from 2021 to 2030.
Next generation sequencing (NGS, NextGenSeq) is used for sequencing genomes at high speed and at low cost. It is also known as second generation sequencing (SGS) or massively parallel sequencing (MPS). The technology is used to determine the order of nucleotides in entire genomes or targeted regions of DNA or RNA This technology is used for the identification of biomarkers for early diagnosis as well as personalized treatments, which has significantly impacted the change of the traditional medicine model of diagnosis to a precision medicine model.
The impact of COVID-19 pandemic is expected to remain positive for the next generation sequencing industry. As Next-generation sequencing (NGS) diagnostic technology has the potential advantage of determining the genetic sequence of a virus and helping scientists understand the mutation of the virus. Furthermore, genome sequencing has been used to understand the spread of Covid-19 and has the potential to understand the impact of interventions and help guide treatments in the future. For instance, Covid-19 Genomics U.K. Consortium (COG-U.K.) was formed in March 2020 to analyze the coronavirus genome using Whole-Genome Sequencing (WGS. To fight against COVID -19 pandemic researchers and scientists together way to identify the new strain of corona virus without any prior knowledge organisms.
A huge number of researches were conducted on DNA and RNA of corona virus to understand how it enters human cells and to learn about its pathogenesis.
For instance, in June 2020, U.S. Food and Drug Administration announced the emergency use authorization (EUA) to Illumina, Inc., for first COVID-19 diagnostic test by using next generation sequence technology to identify the COVID-19 variants with rapid turnaround time. Subsequently, this leads to increase in demand for next generation sequencing technology in any biotechnology & pharma companies, universities, and laboratories.
Rise in technological advancements, especially nanopore sequencing in NGS, rise in the number of collaborations & partnerships to promote the use of NGS in hospitals & research centers, and increase in genome mapping programs throughout the world. For instance, in June 2021, Labcorp, a global leading life science company, and OmniSeq, a molecular diagnostic of Rosewell Park Comprehensive Cancer Center, together announced the launch of OmniSeq INSIGHT which is a next generation sequencing platform in order to advance the precision oncology and improve patient outcome. Moreover, in 2020, Quest Diagnostic, the world largest database of clinical lab results, launched automated next generation sequencing engine to provide accurate genetic testing for inherited disease. In addition, increase in investment in R&D activities increases the demand for NGS; thereby, providing lucrative opportunities for the market growth. However, accuracy & standardization concerns and ethical & legal limitations associated with NGS restrain the market growth.
By product type segment, the consumable segment held the largest share in 2020 and is anticipated to maintain its dominance during the forecast period. This large share is attributed to the fact that they are widely used throughout the sample preparation process and other pre-requisite steps of NGS. The service segment is estimated to grow at the highest CAGR 19.3% during the forecast period. Owing to technological advancements in sequencing platforms, surge in applications of next generation sequencing, and increase in genome mapping programs is going to boost the global next generation sequencing market in future.
North America accounted for the largest share in 2020, and is anticipated to maintain its dominance from 2020 to 2030, due to high expenditure on R&D, presence of major players & their product availability, and well-established healthcare infrastructure in the region. However, Asia-Pacific is expected to register the highest CAGR during the forecast period, as Governments of Asian countries are investing in the development of healthcare infrastructure
The next generation sequencing market is segmented on the basis of product type, application, technology, end user and region. By product, the market is classified into consumables, platforms, and services.
The consumables product segment is further classified based on sample preparation consumables and other consumables. The sample preparation consumables are further segmented into DNA fragmentation, end repair, A-Tailing & size selection, library preparation & target enrichment, and quality control. The platform NGS product segment is segmented into HiSeq, MiSeq, Ion Torrent, SOLiD, Pacbio Rs II & Sequel System, and other sequencing platforms. The services segment is divided into sequencing services and data management. By application, this market is divided into biomarkers & cancer, diagnostics, reproductive health, personalized medicine, agriculture & animal research, and other applications. By technology, the next generation sequencing technology market is classified into sequencing by synthesis, ion semiconductor sequencing, sequencing by ligation, pyrosequencing, single molecule real time sequencing, and other technologies. On the basis of end user, the market is classified into academic & research centers, pharmaceutical and biotechnology companies, hospital & clinics and other end user. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report provides some of the key players operating in the next generation sequencing market include Illumine, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences of California, Inc., Beijing Genomics Institute, Qiagen N.V., 454 Life Sciences Corporation (Roche Holding AG), Agilent Technologies, Inc. PerkinElmer, Inc., Genomatix GmbH, and PierianDx. and among others.
Key Findings Of The Study
Talk to David (Europe)
Talk to Sona Padman (Americas)
5933 NE Win Sivers Drive #205,
Portland, OR 97220 United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91 2066346060
Fax: +1(855) 550-5975
Allied Market Research
Contact Toll Free: +1-800-792-5285
Drop us an email at
media@alliedmarketresearch.com
Next Generation Sequencing Market by Product (Consumables, Platforms, Services and Nerve Blockers), Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Agriculture and Animal Research, and Other Applications), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, and Other Technologies), and End User (Academic and Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Other End Users): Global Opportunity Analysis and Industry Forecast, 2021––2030
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Buy Full Version
"Next generation sequencing market is expected to reach $35,503.66 million by 2030"
Purchase Enquiry
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of the scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save the time of readers